ID

39612

Beskrivning

Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration

Nyckelord

Versioner (1)
  1. 2020-02-03 2020-02-03 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

3 februari 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055

Engelsk

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 Formulär  
Re-Screening data
Beskrivning

Re-Screening data

Alias
UMLS CUI-1
C0220908
UMLS CUI-2
C1511726
Was subject re-screened for this trial?
Beskrivning

Was subject re-screened for this trial?

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
If subject was re-screened for this trial, record original Subject Number
Beskrivning

If subject was re-screened for this trial, record original Subject Number

Datatyp

text

Alias
UMLS CUI [1,1]
C0220908
UMLS CUI [1,2]
C2347804
UMLS CUI [2]
C2348585
Study Eye
Beskrivning

Study Eye

Alias
UMLS CUI-1
C0008972
UMLS CUI-2
C0015392
Study Eye Identification
Beskrivning

Study Eye Identification

Datatyp

text

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0015392
UMLS CUI [1,3]
C0205396
Ranibizumab Injection
Beskrivning

Ranibizumab Injection

Alias
UMLS CUI-1
C1566537
UMLS CUI-2
C1272883
Date and Time of ranibizumab injection in the study eye
Beskrivning

Date and Time of ranibizumab injection in the study eye

Datatyp

datetime

Alias
UMLS CUI [1,1]
C1566537
UMLS CUI [1,2]
C1272883
UMLS CUI [1,3]
C0011008
UMLS CUI [1,4]
C0040223
UMLS CUI [2,1]
C0008972
UMLS CUI [2,2]
C0015392
Tillbaka till toppen

Similar models

Screen - Re-Screening data; Study Eye; Ranibizumab Injection

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Re-Screening data
C0220908 (UMLS CUI-1)
C1511726 (UMLS CUI-2)
Was subject re-screened for this trial?
Item
Was subject re-screened for this trial?
boolean
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
If subject was re-screened for this trial, record original Subject Number
Item
If subject was re-screened for this trial, record original Subject Number
text
C0220908 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
C2348585 (UMLS CUI [2])
Item Group
Study Eye
C0008972 (UMLS CUI-1)
C0015392 (UMLS CUI-2)
Item
Study Eye Identification
text
C0008972 (UMLS CUI [1,1])
C0015392 (UMLS CUI [1,2])
C0205396 (UMLS CUI [1,3])
Study Eye Identification
Code List
Study Eye Identification
CL Item
Right (R)
CL Item
Left (L)
Item Group
Ranibizumab Injection
C1566537 (UMLS CUI-1)
C1272883 (UMLS CUI-2)
Date and Time of ranibizumab injection in the study eye
Item
Date and Time of ranibizumab injection in the study eye
datetime
C1566537 (UMLS CUI [1,1])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial